CDKN2A encodes for p16INK4a, a protein that acts as a tumor suppressor gene and is involved in the modulation of cell cycle progression, thus explaining why CDKN2A deletion is a frequent event in cancer establishment [38]. This evidence concerns the gene CDKN2A and cancer.